MingSight
Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed MingSight Information
Geographic Data
Address: PO Box 261208
City: San Diego
State: CA
Zip: 92196
Country: US
Financial Info
Stage:
series b
Raised Last:
$20M
Raised Total:$20M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Mingsight, an ophthalmic medical drug developer, has initiated a clinical trial of the original innovative drug MS-553 in patients with diabetic retinopathy. This study is the world&s;s first clinical trial of MS-553 in this indication. In the field of CLL treatment, MS-533 can be used alone or in combination with ibrutinib, BCL-2, etc., initially showing outstanding clinical value and market potential in the treatment of patients with C481S and PLCG2 mutations; in the field of DME treatment, MS-533 can be taken orally to achieve enrichment in the retina of the fundus, avoiding the need for vitreous injection of drugs such as ranibizumab, and clinical data such as BCVA/CRT of patients also initially show the efficacy of the product.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2021 | Series B | 1 | $20M |
Kaitai Capital Kaitai Capital |
11/2021 | Equity | $10M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
